STOCK TITAN

Freshpet, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Freshpet (NASDAQ: FRPT) reported strong financial results for Q4 and full year 2024. Fourth quarter net sales increased 22.0% to $262.7 million, with net income of $18.1 million. Full year 2024 saw net sales rise 27.2% to $975.2 million, with net income of $46.9 million compared to a prior year loss of $33.6 million.

The company demonstrated significant margin improvements, with Q4 gross margin reaching 42.5% (up from 34.6%) and adjusted EBITDA of $52.6 million (up from $31.3 million). Operating cash flow for 2024 was $154.3 million, nearly double the previous year.

Looking ahead, Freshpet provided 2025 guidance projecting net sales between $1.18-1.21 billion and adjusted EBITDA of at least $210 million. The company also updated its 2027 targets, maintaining $1.8 billion in net sales while raising adjusted gross margin to 48% and adjusted EBITDA margin to 22%.

Freshpet (NASDAQ: FRPT) ha riportato risultati finanziari solidi per il quarto trimestre e per l'intero anno 2024. Le vendite nette del quarto trimestre sono aumentate del 22,0% a $262,7 milioni, con un reddito netto di $18,1 milioni. Nell'intero anno 2024, le vendite nette sono aumentate del 27,2% a $975,2 milioni, con un reddito netto di $46,9 milioni rispetto a una perdita di $33,6 milioni dell'anno precedente.

L'azienda ha dimostrato significativi miglioramenti dei margini, con un margine lordo del quarto trimestre che ha raggiunto il 42,5% (rispetto al 34,6%) e un EBITDA rettificato di $52,6 milioni (rispetto ai $31,3 milioni). Il flusso di cassa operativo per il 2024 è stato di $154,3 milioni, quasi il doppio rispetto all'anno precedente.

Guardando al futuro, Freshpet ha fornito indicazioni per il 2025 prevedendo vendite nette comprese tra $1,18-1,21 miliardi e un EBITDA rettificato di almeno $210 milioni. L'azienda ha anche aggiornato i suoi obiettivi per il 2027, mantenendo vendite nette di $1,8 miliardi mentre ha aumentato il margine lordo rettificato al 48% e il margine EBITDA rettificato al 22%.

Freshpet (NASDAQ: FRPT) informó resultados financieros sólidos para el cuarto trimestre y todo el año 2024. Las ventas netas del cuarto trimestre aumentaron un 22,0% a $262,7 millones, con una ganancia neta de $18,1 millones. En todo el año 2024, las ventas netas crecieron un 27,2% a $975,2 millones, con una ganancia neta de $46,9 millones en comparación con una pérdida de $33,6 millones del año anterior.

La compañía demostró mejoras significativas en los márgenes, con un margen bruto del cuarto trimestre alcanzando el 42,5% (frente al 34,6%) y un EBITDA ajustado de $52,6 millones (frente a $31,3 millones). El flujo de efectivo operativo para 2024 fue de $154,3 millones, casi el doble que el año anterior.

De cara al futuro, Freshpet proporcionó una guía para 2025 proyectando ventas netas entre $1,18-1,21 mil millones y un EBITDA ajustado de al menos $210 millones. La empresa también actualizó sus objetivos para 2027, manteniendo $1,8 mil millones en ventas netas mientras que elevó el margen bruto ajustado al 48% y el margen EBITDA ajustado al 22%.

프레시펫 (NASDAQ: FRPT)는 2024년 4분기 및 전체 연도의 강력한 재무 결과를 보고했습니다. 4분기 순매출은 22.0% 증가하여 2억 6,270만 달러에 달했으며, 순이익은 1,810만 달러였습니다. 2024년 전체 연도에는 순매출이 27.2% 증가하여 9억 7,520만 달러에 이르렀으며, 순이익은 4,690만 달러로, 전년 대비 3,360만 달러의 손실에서 개선되었습니다.

회사는 4분기 총 이익률이 42.5%에 도달(34.6%에서 상승)하고 조정된 EBITDA가 5,260만 달러(3,130만 달러에서 상승)로 증가하는 등 상당한 마진 개선을 보여주었습니다. 2024년 운영 현금 흐름은 1억 5,430만 달러로, 전년 대비 거의 두 배 증가했습니다.

미래를 바라보며, 프레시펫은 2025년 순매출을 11억 8천만에서 12억 1천만 달러로 예상하고, 최소 2억 1천만 달러의 조정된 EBITDA를 목표로 하는 가이드를 제공했습니다. 또한 2027년 목표를 업데이트하여 순매출 18억 달러를 유지하면서 조정된 총 이익률을 48%로, 조정된 EBITDA 마진을 22%로 상향 조정했습니다.

Freshpet (NASDAQ: FRPT) a annoncé des résultats financiers solides pour le quatrième trimestre et l'année entière 2024. Les ventes nettes du quatrième trimestre ont augmenté de 22,0 % pour atteindre 262,7 millions de dollars, avec un bénéfice net de 18,1 millions de dollars. Pour l'année entière 2024, les ventes nettes ont augmenté de 27,2 % pour atteindre 975,2 millions de dollars, avec un bénéfice net de 46,9 millions de dollars par rapport à une perte de 33,6 millions de dollars l'année précédente.

L'entreprise a démontré des améliorations significatives des marges, avec une marge brute du quatrième trimestre atteignant 42,5 % (contre 34,6 %) et un EBITDA ajusté de 52,6 millions de dollars (contre 31,3 millions de dollars). Le flux de trésorerie d'exploitation pour 2024 était de 154,3 millions de dollars, soit presque le double de l'année précédente.

En regardant vers l'avenir, Freshpet a fourni des prévisions pour 2025, projetant des ventes nettes entre 1,18 et 1,21 milliard de dollars et un EBITDA ajusté d'au moins 210 millions de dollars. L'entreprise a également mis à jour ses objectifs pour 2027, maintenant des ventes nettes de 1,8 milliard de dollars tout en augmentant la marge brute ajustée à 48 % et la marge EBITDA ajustée à 22 %.

Freshpet (NASDAQ: FRPT) berichtete über starke finanzielle Ergebnisse für das vierte Quartal und das gesamte Jahr 2024. Der Nettoumsatz im vierten Quartal stieg um 22,0% auf 262,7 Millionen USD, mit einem Nettogewinn von 18,1 Millionen USD. Im gesamten Jahr 2024 stiegen die Nettoumsätze um 27,2% auf 975,2 Millionen USD, mit einem Nettogewinn von 46,9 Millionen USD im Vergleich zu einem Verlust von 33,6 Millionen USD im Vorjahr.

Das Unternehmen zeigte erhebliche Verbesserungen der Margen, wobei die Bruttomarge im vierten Quartal 42,5% erreichte (von 34,6% gestiegen) und das bereinigte EBITDA 52,6 Millionen USD betrug (von 31,3 Millionen USD gestiegen). Der operative Cashflow für 2024 betrug 154,3 Millionen USD, was fast doppelt so viel wie im Vorjahr ist.

Für die Zukunft gab Freshpet eine Prognose für 2025 ab und erwartet Nettoumsätze zwischen 1,18 und 1,21 Milliarden USD sowie ein bereinigtes EBITDA von mindestens 210 Millionen USD. Das Unternehmen aktualisierte auch seine Ziele für 2027 und hielt die Nettoumsätze bei 1,8 Milliarden USD, während die bereinigte Bruttomarge auf 48% und die bereinigte EBITDA-Marge auf 22% angehoben wurde.

Positive
  • Net sales increased 27.2% to $975.2 million in 2024
  • Achieved first full-year positive net income of $46.9 million
  • Q4 gross margin improved to 42.5% from 34.6%
  • Operating cash flow doubled to $154.3 million
  • Strong cash position with $268.6 million in cash and cash equivalents
Negative
  • SG&A expenses increased to $92.2 million in Q4 2024 from $59.7 million
  • Significant planned capital expenditure of ~$250 million for 2025
  • Total debt of $395.2 million outstanding

Insights

Freshpet's Q4 and FY2024 results mark a transformative milestone in the company's evolution from a high-growth, negative-profit enterprise to a sustainably profitable business model. The 27.2% full-year revenue growth, driven predominantly by volume gains of 26.1%, demonstrates robust consumer demand and successful market penetration without heavy reliance on price increases.

The dramatic improvement in gross margins, expanding 790 basis points year-over-year to 40.6%, reflects successful operational optimization and economies of scale. This efficiency gain, coupled with $154.3 million in operating cash flow, validates the company's manufacturing strategy and suggests a clear path to profitable scaling.

The 2025 guidance and updated 2027 targets reveal management's increased confidence in operational leverage. The projected Adjusted EBITDA margin of 22% by 2027, up from the previous 18% target, indicates potential for sustained margin expansion beyond current levels. The planned $250 million capital expenditure for 2025 demonstrates a strategic reinvestment in growth while maintaining strong cash positions of $268.6 million.

Most significantly, the company's projection of achieving free cash flow positive status by 2026 marks a important inflection point. This transition to self-funded growth reduces reliance on external capital and potentially lowers the cost of capital, creating a virtuous cycle for sustainable expansion in the premium pet food segment.

Significant Margin Improvement & Strong Cash Generation Provides Full Year 2025 Outlook and Updates 2027 Targets

BEDMINSTER, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today reported financial results for its fourth quarter and full year ended December 31, 2024.

Fourth Quarter 2024 Financial Highlights Compared to Prior Year Period

  • Net sales of $262.7 million, an increase of 22.0%.
  • Net income of $18.1 million, compared to the prior year period of $15.3 million.
  • Gross margin of 42.5%, compared to the prior year period of 34.6%.
  • Adjusted Gross Margin of 48.1%, compared to the prior year period of 41.1%.1
  • Adjusted EBITDA of $52.6 million, compared to the prior year period of $31.3 million.1

Full Year 2024 Financial Highlights Compared to Prior Year

  • Net sales of $975.2 million, an increase of 27.2%.
  • Net income of $46.9 million, compared to the prior year net loss of $33.6 million.
  • Gross margin of 40.6%, compared to the prior year of 32.7%.
  • Adjusted Gross Margin of 46.5%, compared to the prior year of 40.0%.1
  • Adjusted EBITDA of $161.8 million, compared to the prior year of $66.6 million.1
  • For the year ended December 31, 2024, net cash provided by operating activities was $154.3 million, compared to $75.9 million in the prior year.

"Fiscal year 2024 was a breakout year for Freshpet. We continued to deliver the exceptional net sales growth investors have come to expect from Freshpet but also delivered very strong profit improvements - and even exceeded some of the fiscal year 2027 targets we set two years ago. We also delivered full-year positive net income for the first time. The strength of this sustained performance, coupled with our operating cash flow improvements, gives us confidence we will be free cash flow positive in 2026 and able to self-fund our growth going forward," commented Billy Cyr, Freshpet’s Chief Executive Officer. "This strong performance also enables us to raise our long-term profit margin targets today to reflect the additional scale benefits we believe we can deliver as we transform the pet food category and nourish pets, people, and the planet. We remain focused on delivering disciplined, consistent growth, and outsized profitability improvements, that we believe will drive shareholder value going forward."

Fourth Quarter 2024

Net sales increased 22.0% to $262.7 million for the fourth quarter of 2024 compared to $215.4 million for the prior year period. The increase in net sales was primarily driven by volume gains of 20.7%.

Gross profit was $111.6 million, or 42.5% as a percentage of net sales, for the fourth quarter of 2024, compared to $74.6 million, or 34.6% as a percentage of net sales, for the prior year period. The increase in reported gross profit as a percentage of net sales was primarily due to lower input costs, reduced quality costs and improved leverage on plant expenses. For the fourth quarter of 2024, Adjusted Gross Profit was $126.3 million, or 48.1% as a percentage of net sales, compared to $88.5 million, or 41.1% as a percentage of net sales, for the prior year period.1

Selling, general and administrative expenses (“SG&A”) were $92.2 million for the fourth quarter of 2024 compared to $59.7 million for the prior year period. SG&A as a percentage of net sales increased by 740 basis points to 35.1% for the fourth quarter of 2024 compared to 27.7% for the prior year period, primarily due to increased media as a percentage of net sales, higher share-based compensation and increased variable compensation accrual. Adjusted SG&A for the fourth quarter of 2024 was $73.6 million, or 28.0% as a percentage of net sales, compared to $57.2 million, or 26.6% as a percentage of net sales, for the prior year period.1

Net income was $18.1 million for the fourth quarter of 2024 compared to $15.3 million for the prior year period. The increase in net income was due to contribution from higher sales and improved gross margin, partially offset by increased SG&A.

Adjusted EBITDA was $52.6 million for the fourth quarter of 2024 compared to $31.3 million for the prior year period.1 The increase in Adjusted EBITDA was a result of increased Adjusted Gross Profit, partially offset by higher Adjusted SG&A.

Full Year 2024

Net sales increased 27.2% to $975.2 million for the full year ended December 31, 2024, compared to $766.9 million for the prior year. The increase in net sales was primarily driven by volume gains of 26.1%.

Gross profit was $396.0 million, or 40.6% as a percentage of net sales, for the full year ended December 31, 2024, compared to $250.9 million, or 32.7% as a percentage of net sales, for the prior year. The increase in reported gross profit as a percentage of net sales was primarily due to lower input costs, reduced quality costs and improved leverage on plant expenses. For the full year ended December 31, 2024, Adjusted Gross Profit was $453.5 million, or 46.5% as a percentage of net sales, compared to $306.6 million, or 40.0% as a percentage of net sales, for the prior year.1

SG&A was $358.0 million for the full year ended December 31, 2024, compared to $281.3 million for the prior year. As a percentage of net sales, SG&A remained consistent at 36.7% for both the full years ended December 31, 2024 and 2023. SG&A as a percentage of net sales remained consistent as the decreases due to reduced logistics as a percentage of net sales and the absence of non-recurring charges incurred in the prior year were fully offset by increased media as a percentage of net sales, higher share-based compensation and increased variable compensation accrual. Adjusted SG&A for the full year ended December 31, 2024 was $291.6 million, or 29.9% as a percentage of net sales, compared to $240.1 million, or 31.3% as a percentage of net sales, for the prior year.1

Net income was $46.9 million for the full year ended December 31, 2024, compared to a net loss of $33.6 million for the prior year. The improvement in net income was due to contribution from higher sales, improved gross margin, reduced logistics costs as a percentage of net sales, and gain on equity investment, partially offset by increased SG&A.

Adjusted EBITDA was $161.8 million for the full year ended December 31, 2024, compared to $66.6 million for the prior year.1 The increase in Adjusted EBITDA was a result of increased Adjusted Gross Profit partially offset by higher Adjusted SG&A.

Balance Sheet

As of December 31, 2024, the Company had cash and cash equivalents of $268.6 million with $395.2 million of debt outstanding net of $7.3 million of unamortized debt issuance costs. For the year ended December 31, 2024, cash from operations was $154.3 million, an increase of $78.3 million compared to the prior year.

The Company will utilize its balance sheet to support its ongoing capital needs in connection with its long-term capacity plan.

1 Adjusted Gross Margin, Adjusted Gross Profit, Adjusted SG&A and Adjusted EBITDA are non-GAAP financial measures. See "Non-GAAP Measures" for how the Company defines these measures and the financial tables that accompany this release for reconciliations of these measures to the closest comparable GAAP measures.

Outlook

For full year 2025, the Company is providing the following guidance:

  • Net sales in the range of $1.18 billion to $1.21 billion, an increase of 21% to 24% from 2024;
  • Adjusted EBITDA of at least $210 million; and
  • Capital expenditures of ~$250 million.

The Company is also updating its long-term guidance. For full year 2027, the Company now expects:

  • Net sales of $1.8 billion, unchanged;
  • Adjusted Gross Margin of 48%, compared to 45% previously; and
  • Adjusted EBITDA margin of 22%, compared to 18% previously.

The Company does not provide guidance for net income (loss), the U.S. GAAP measure most directly comparable to Adjusted EBITDA, and similarly cannot provide a reconciliation between its forecasted Adjusted EBITDA and net income (loss) metrics without unreasonable effort due to the unavailability of reliable estimates for certain components of net income (loss) and the respective reconciliations, including the timing of and amount of costs of goods sold and selling, general and administrative expenses. These items are not within the Company's control and may vary greatly between periods and could significantly impact future results.

Conference Call & Earnings Presentation Webcast Information
As previously announced, today, February 20, 2025, the Company will host a conference call with members of its leadership team. The conference call webcast is scheduled to begin at 6:30 a.m. ET and will be hosted and archived on the "Investors" section of the Company's website at www.freshpet.com. Due to the Company's participation in the 2025 Consumer Analyst Group of New York (CAGNY) Conference, there will not be a question and answer session this quarter.

About Freshpet
Freshpet’s mission is to improve the lives of dogs and cats through the power of fresh, real food. Freshpet foods are blends of fresh meats, vegetables and fruits farmed locally and made at our Freshpet Kitchens. We thoughtfully prepare our foods using natural ingredients, cooking them in small batches at lower temperatures to preserve the natural goodness of the ingredients. Freshpet foods and treats are kept refrigerated from the moment they are made until they arrive at Freshpet Fridges in your local market.

Our foods are available in select grocery, mass, digital, pet specialty, and club retailers across the United States, Canada and Europe. From the care we take to source our ingredients and make our food, to the moment it reaches your home, our integrity, transparency and social responsibility are the way we like to run our business. To learn more, visit www.freshpet.com.

Connect with Freshpet:

https://www.facebook.com/Freshpet

https://x.com/Freshpet

http://instagram.com/Freshpet

http://pinterest.com/Freshpet

https://www.tiktok.com/@Freshpet

https://www.youtube.com/user/freshpet400

Forward Looking Statements

Certain statements in this release constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to our ability to achieve our 2027 targets, create meaningful shareholder value, and guidance with respect to 2024 net sales, Adjusted EBITDA and capital expenditures. These statements are based on management's current opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results. While Freshpet believes that its assumptions are reasonable, it is very difficult to predict the impact of known factors, and, of course, it is impossible to anticipate all factors that could affect actual results. There are several risks and uncertainties which could cause actual results, performance, and achievements to differ materially from those stated or implied by the forward-looking statements described herein, including, most prominently, the risks discussed under the heading “Risk Factors” in the Company's latest annual report on Form 10-K and its quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release. Freshpet undertakes no obligation to publicly update or revise any forward-looking statement because of new information, future events or otherwise, except as otherwise required by law. If we do update one or more forward-looking statements, no inference should be made that we will make additional updates with respect to those or other forward-looking statements.

Non-GAAP Financial Measures

Freshpet uses the following non-GAAP financial measures in its financial communications. These non-GAAP financial measures should be considered as supplements to the U.S. GAAP reported measures, should not be considered replacements for, or superior to, the U.S. GAAP measures and may not be comparable to similarly named measures used by other companies.

  • Adjusted Gross Profit
  • Adjusted Gross Profit as a percentage of net sales (Adjusted Gross Margin)
  • Adjusted SG&A Expenses
  • Adjusted SG&A Expenses as a percentage of net sales
  • EBITDA
  • Adjusted EBITDA
  • Adjusted EBITDA as a percentage of net sales

Adjusted Gross Profit: Freshpet defines Adjusted Gross Profit as gross profit before depreciation expense, non-cash share-based compensation and loss on disposal of manufacturing equipment.

Adjusted SG&A Expenses: Freshpet defines Adjusted SG&A as SG&A expenses before depreciation and amortization expense, non-cash share-based compensation, implementation and other costs associated with the implementation of an enterprise resource planning ("ERP") system, fees related to the capped call transactions, loss on disposal of equipment, advisory fees related to shareholder activism defense engagement, and organizational changes.

EBITDA and Adjusted EBITDA: EBITDA represents net income (loss) plus interest expense net of interest income, income tax expense and depreciation and amortization expense, and Adjusted EBITDA represents EBITDA less gain on equity investment, plus loss on equity method investment, non-cash share-based compensation expense, implementation and other costs associated with the implementation of an ERP system, loss on disposal of property, plant and equipment, fees related to the capped call transactions, advisory fees related to shareholder activism defense engagement, and organizational changes.

Management believes that the non-GAAP financial measures are meaningful to investors because they provide a view of the Company with respect to ongoing operating results. The non-GAAP financial measures are shown as supplemental disclosures in this release because they are widely used by the investment community for analysis and comparative evaluation. They also provide additional metrics to evaluate the Company’s operations and, when considered with both the Company’s GAAP results and the reconciliation to the most comparable U.S. GAAP measures, provide a more complete understanding of the Company’s business than could be obtained absent this disclosure. The non-GAAP measures are not and should not be considered an alternative to the most comparable U.S. GAAP measures or any other figure calculated in accordance with U.S. GAAP, or as an indicator of operating performance. The Company’s calculation of the non-GAAP financial measures may differ from methods used by other companies. Management believes that the non-GAAP measures are important to an understanding of the Company's overall operating results in the periods presented. The non-GAAP financial measures are not recognized in accordance with U.S. GAAP and should not be viewed as an alternative to U.S. GAAP measures of performance.

Investor Contact:
Rachel Ulsh
Rulsh@freshpet.com

Media Contact:
Press@freshpet.com

 
FRESHPET, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
 
 December 31,
2024
 December 31,
2023
ASSETS   
CURRENT ASSETS:   
Cash and cash equivalents$268,633  $296,871 
Accounts receivable, net of allowance for doubtful accounts 68,419   56,754 
Inventories, net 80,794   63,238 
Prepaid expenses 16,026   7,615 
Other current assets 3,126   2,841 
Total Current Assets 436,998   427,319 
Property, plant and equipment, net 1,065,869   979,164 
Deposits on equipment 1,047   1,895 
Operating lease right of use assets 3,366   3,616 
Long term investment in equity securities 33,446   23,528 
Other assets 34,152   28,899 
Total Assets$1,574,878  $1,464,421 
LIABILITIES AND STOCKHOLDERS' EQUITY   
CURRENT LIABILITIES:   
Accounts payable$39,164  $36,096 
Accrued expenses 56,263   49,816 
Current operating lease liabilities 1,322   1,312 
Current finance lease liabilities 2,120   1,998 
Total Current Liabilities$98,869  $89,222 
Convertible senior notes 395,163   393,074 
Long term operating lease liabilities 2,213   2,591 
Long term finance lease liabilities 23,273   26,080 
Total Liabilities$519,518  $510,967 
Commitments and contingencies     
STOCKHOLDERS' EQUITY:   
Common stock — voting, $0.001 par value, 200,000 shares authorized, 48,716 issued and 48,702 outstanding on December 31, 2024, and 48,277 issued and 48,263 outstanding on December 31, 2023 49   48 
Additional paid-in capital 1,338,160   1,282,984 
Accumulated deficit (281,806)  (328,731)
Accumulated other comprehensive loss (787)  (591)
Treasury stock, at cost — 14 shares on December 31, 2024 and on December 31, 2023 (256)  (256)
Total Stockholders' Equity 1,055,360   953,454 
Total Liabilities and Stockholders' Equity$1,574,878  $1,464,421 


 
FRESHPET, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(In thousands, except per share data)
 
 Three Months Ended
December 31,
 Year Ended
December 31,
  2024   2023   2024   2023 
 (Unaudited)    
        
NET SALES$262,708  $215,420  $975,177  $766,895 
COST OF GOODS SOLD 151,108   140,846   579,221   516,023 
GROSS PROFIT 111,600   74,575   395,956   250,872 
SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES 92,223   59,680   357,957   281,318 
INCOME (LOSS) FROM OPERATIONS 19,377   14,895   37,999   (30,446)
OTHER INCOME (EXPENSES):       
Interest and Other Income, net 2,710   3,843   11,868   13,029 
Interest Expense (3,528)  (3,449)  (12,262)  (14,097)
Gain on Equity Investment       9,918    
  (818)  394   9,524   (1,068)
INCOME (LOSS) BEFORE INCOME TAXES 18,559   15,289   47,523   (31,514)
INCOME TAX EXPENSE 436      598   210 
LOSS ON EQUITY METHOD INVESTMENT          1,890 
INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS$18,123  $15,289  $46,925  $(33,614)
OTHER COMPREHENSIVE (LOSS) INCOME:       
Change in foreign currency translation$(603) $368  $(196) $(1,961)
TOTAL OTHER COMPREHENSIVE (LOSS) INCOME (603)  368   (196)  (1,961)
TOTAL COMPREHENSIVE INCOME (LOSS)$17,520  $15,657  $46,729  $(35,575)
NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS       
-BASIC$0.37  $0.32  $0.97  $(0.70)
-DILUTED$0.36  $0.31  $0.93  $(0.70)
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING       
-BASIC 48,642   48,244   48,487   48,163 
-DILUTED 50,407   49,889   50,255   48,163 


 
FRESHPET, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF CASH FLOWS
(In thousands)
 
 Year Ended
December 31,
  2024   2023   2022 
CASH FLOWS FROM OPERATING ACTIVITIES:     
Net income (loss)$46,925  $(33,614) $(59,494)
Adjustments to reconcile net income (loss) to net cash flows provided by operating activities:     
Provision for loss (gains) on accounts receivable 467   (2)  (20)
Loss on disposal of property, plant and equipment 1,284   4,321   396 
Share-based compensation 51,807   24,935   26,092 
Inventory obsolescence 347      3,455 
Depreciation and amortization 73,615   58,517   34,555 
Write-off and amortization of deferred financing costs and loan discount 2,089   4,060   795 
Change in operating lease right of use asset 1,350   1,549   1,372 
Loss on equity method investment    1,890   3,731 
Gain on equity investment (9,918)      
Changes in operating assets and liabilities:     
Accounts receivable (12,228)  820   (32,993)
Inventories (15,484)  (1,207)  (26,171)
Prepaid expenses and other current assets 269   (2,249)  (435)
Other assets (5,063)  (4,053)  (3,141)
Accounts payable 12,484   3,543   (3,063)
Accrued expenses 7,811   19,237   13,078 
Operating lease liability (1,467)  (1,807)  (1,384)
Net cash flows provided by (used in) operating activities 154,288   75,940   (43,227)
CASH FLOWS FROM INVESTING ACTIVITIES:     
Acquisitions of property, plant and equipment, software and deposits on equipment (187,092)  (239,093)  (230,071)
Purchase of short-term investments    (113,441)  (19,840)
Proceeds from maturities of short-term investments   113,441   19,840 
Investments in equity method investment       (3,293)
Net cash flows used in investing activities (187,092)  (239,093)  (233,364)
CASH FLOWS FROM FINANCING ACTIVITIES:     
Proceeds from exercise of options to purchase common stock 9,138   4,517   471 
Tax withholdings related to net shares settlements of restricted stock units (2,595)  (1,400)  (1,441)
Principal payments under finance lease obligations (1,977)  (1,109)   
Purchase of capped call options    (66,211)   
Proceeds from issuance of convertible senior notes    393,518    
Debt issuance costs    (2,026)   
Proceeds from borrowings under Credit Facility       78,000 
Repayment of borrowings under Credit Facility       (78,000)
Proceeds from common shares issued in primary offering, net of issuance cost       337,508 
Net cash flows provided by financing activities 4,566   327,289   336,538 
NET CHANGE IN CASH AND CASH EQUIVALENTS (28,238)  164,136   59,947 
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 296,871   132,735   72,788 
CASH AND CASH EQUIVALENTS, END OF PERIOD$268,633  $296,871  $132,735 


 
FRESHPET, INC. AND SUBSIDIARIES
RECONCILIATION BETWEEN GROSS PROFIT AND ADJUSTED GROSS PROFIT
 
 Three Months Ended
December 31,
 Year Ended
December 31,
  2024   2023   2024   2023 
 (Dollars in thousands)
Gross profit$111,600  $74,575  $395,956  $250,872 
Depreciation expense 13,358   8,103   49,056   41,209 
Non-cash share-based compensation 1,310   2,299   7,761   10,995 
Loss on disposal of manufacturing equipment 5   3,547   696   3,547 
Adjusted Gross Profit$126,273  $88,524  $453,469  $306,623 
Adjusted Gross Profit as a % of Net Sales 48.1%  41.1%  46.5%  40.0%


 
FRESHPET, INC. AND SUBSIDIARIES
RECONCILIATION BETWEEN SG&A EXPENSES AND ADJUSTED SG&A EXPENSES
 
 Three Months Ended
December 31,
 Year Ended
December 31,
  2024   2023   2024   2023 
 (Dollars in thousands)
SG&A expenses$92,223  $59,680  $357,957  $281,318 
Depreciation and amortization expense 5,780   4,248   21,747   15,849 
Non-cash share-based compensation (a) 12,635   (2,315)  44,045   13,941 
Loss on disposal of equipment 225   86   588   774 
Enterprise Resource Planning (b)    465      2,457 
Capped Call Transactions fees (c)          113 
Shareholder activism defense engagement (d)          8,177 
Organization changes (e)          (67)
Adjusted SG&A Expenses$73,583  $57,196  $291,577  $240,074 
Adjusted SG&A Expenses as a % of Net Sales 28.0%  26.6%  29.9%  31.3%


(a)Includes true-ups to share-based compensation expense compared to prior periods. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA and/or Net Sales targets as a condition of vesting. At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets. When the probability of achieving such performance conditions changes, the compensation cost previously recorded is adjusted as needed. When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed.
(b)Represents costs associated with the implementation of an ERP system.
(c)Represents fees associated with the Capped Call Transactions associated with our sale of Convertible Notes in 2023.
(d)Represents advisory fees related to shareholder activism defense engagement.
(e)Represents a true-up to transition costs related to the organization changes designed to support growth, including several changes in organizational structure designed to enhance capabilities and support long-term growth objectives.


 
FRESHPET, INC. AND SUBSIDIARIES
RECONCILIATION BETWEEN NET INCOME (LOSS) AND ADJUSTED EBITDA
 
 Three Months Ended
December 31,
 Year Ended
December 31,
  2024   2023   2024   2023 
 (Dollars in thousands)
Net income (loss)$18,123  $15,289  $46,925  $(33,614)
Depreciation and amortization 19,138   12,351   70,803   57,058 
Interest expense, net of interest income 760   (394)  335   1,069 
Income tax expense 436      598   210 
EBITDA$38,457  $27,246  $118,661  $24,723 
Gain on equity investment$  $  $(9,918) $ 
Loss on disposal of property, plant and equipment 230   3,633   1,284   4,321 
Non-cash share-based compensation (a) 13,946   (16)  51,807   24,936 
Loss on equity method investment          1,890 
Enterprise Resource Planning (b)    465      2,457 
Capped Call Transactions fees (c)          113 
Shareholder activism defense engagement (d)          8,177 
Organization changes (e)          (67)
Adjusted EBITDA$52,633  $31,328  $161,834  $66,550 
Adjusted EBITDA as a % of Net Sales 20.0%  14.5%  16.6%  8.7%


(a)Includes true-ups to share-based compensation expense compared to prior periods. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA and/or Net Sales targets as a condition of vesting. At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets. When the probability of achieving such performance conditions changes, the compensation cost previously recorded is adjusted as needed. When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed.
(b)Represents costs associated with the implementation of an ERP system.
(c)Represents fees associated with the Capped Call Transactions associated with our sale of Convertible Notes in 2023.
(d)Represents advisory fees related to shareholder activism defense engagement.
(e)Represents a true-up to transition costs related to the organization changes designed to support growth, including several changes in organizational structure designed to enhance capabilities and support long-term growth objectives.

FAQ

What was Freshpet's (FRPT) revenue growth in 2024?

Freshpet's net sales increased 27.2% to $975.2 million in 2024, primarily driven by volume gains of 26.1%.

How much profit did FRPT make in Q4 2024?

Freshpet reported a net income of $18.1 million in Q4 2024, compared to $15.3 million in the prior year period.

What is Freshpet's (FRPT) revenue guidance for 2025?

Freshpet expects net sales between $1.18 billion to $1.21 billion in 2025, representing growth of 21% to 24% from 2024.

What are FRPT's margin targets for 2027?

Freshpet updated its 2027 targets to achieve an adjusted gross margin of 48% and adjusted EBITDA margin of 22%.

How much cash does Freshpet (FRPT) have on its balance sheet?

As of December 31, 2024, Freshpet had $268.6 million in cash and cash equivalents.

Freshpet

NASDAQ:FRPT

FRPT Rankings

FRPT Latest News

FRPT Stock Data

5.16B
46.92M
1.86%
109.16%
9.18%
Packaged Foods
Grain Mill Products
Link
United States
BEDMINSTER